Literature DB >> 9111263

Computed tomography in lacrimal outflow obstruction.

J E Kallman1, J A Foster, A E Wulc, D M Yousem, D W Kennedy.   

Abstract

BACKGROUND: Acquired nasolacrimal duct obstruction is a common ophthalmologic problem. Despite widespread understanding of treatments available for nasolacrimal duct obstruction, few authors have commented on its etiology. Because the nasolacrimal system is anatomically related to important nasal and sinus structures, the authors postulated that acquired nasolacrimal duct obstruction and its complications might occur simultaneous to, and possibly as a consequence of, rhinologic or sinus disease.
MATERIALS AND METHODS: Twenty-three patients with acquired nasolacrimal duct obstruction and 100 control patients were evaluated by coronal computed tomography for evidence of sinus disease or nasal abnormalities. Specifically, five findings were noted: ostiomeatal complex disease, ethmoidal opacification, agger nasi cell opacification, concha bullosa, and nasal septal deviation.
RESULTS: Overall, 20 (87%) patients with acquired nasolacrimal duct obstruction demonstrated one or more radiologic finding of sinus disease or rhinologic abnormality whereas 63 (63%) control subjects exhibited these findings. This difference was determined to be statistically significant (P < 0.05). A statistically significant higher incidence of ethmoidal opacification, agger nasi cell opacification, and nasal septal deviation was observed in patients with nasolacrimal outflow obstruction than in controls. Differences in the incidence of ostiomeatal complex disease and concha bullosa were not found to be statistically significant.
CONCLUSION: These data demonstrate a correlation between computed tomography findings of sinus disease or nasal abnormality and the presence of acquired nasolacrimal outflow obstruction. This association between radiologic evidence of sinorhinologic disorders and lacrimal outflow obstruction may imply that dacryocystitis, like sinus disease, may be produced by disease of the lateral nasal wall. When evaluating a patient with acquired nasolacrimal duct obstruction, the physician should consider evaluation for concomitant nasal and sinus disease.

Entities:  

Mesh:

Year:  1997        PMID: 9111263     DOI: 10.1016/s0161-6420(97)30252-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Endoscopic dacryocystorhinostomy: personal experience.

Authors:  L Muscatello; M Giudice; G Spriano; L Tondini
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-08       Impact factor: 2.124

2.  Primary acquired nasolacrimal duct obstruction: is it really related to paranasal abnormalities?

Authors:  Hasmet Yazici; Erdogan Bulbul; Alper Yazici; Mustafa Kaymakci; Nesime Tiskaoglu; Bahar Yanik; Samet Ermis
Journal:  Surg Radiol Anat       Date:  2014-11-25       Impact factor: 1.246

3.  Rhinological Status of Patients with Nasolacrimal Duct Obstruction.

Authors:  Vasily D Yartsev; Eugenia L Atkova; Eugeniy O Rozmanov; Nina D Yartseva
Journal:  Int Arch Otorhinolaryngol       Date:  2021-12-20

4.  Cone-Beam Computed Tomography (CBCT) dacryocystography for imaging of the nasolacrimal duct system.

Authors:  Kai E Wilhelm; Heike Rudorf; Susanne Greschus; Stefan Garbe; Marcel Lüssem; Thomas Lischka; Hans H Schild; Andreas O H Gerstner
Journal:  Klin Neuroradiol       Date:  2009-11-20

5.  Are of Osteomeatal Complex Variations Related to Nasolacrimal Canal Morphometry.

Authors:  Leila Khojastepour; Sonia Dokohaki; Maryam Paknahad
Journal:  Iran J Otorhinolaryngol       Date:  2022-01

6.  Sinonasal Anatomical Variations and Primary Acquired Nasolacrimal Duct Obstruction: A Single Centre, Case-Control Investigation.

Authors:  Reza Samarei; Vafa Samarei; Naser Samadi Aidenloo; Nasrin Fateh
Journal:  Eurasian J Med       Date:  2020-02

7.  Endoscopic intranasal findings in unilateral primary acquired nasolacrimal duct obstruction.

Authors:  Swati Singh; Mohammad Shahid Alam; Mohammad Javed Ali; Milind N Naik
Journal:  Saudi J Ophthalmol       Date:  2017-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.